Microbiology Lab Quiz 5 Review: Helminths, Standard Plate Count, Spectrophotometer, and MSA

Overview of Laboratory Topics

• Helminths ($12-4$): Identification, morphological differentiation, transmission mechanisms, phylum categorization, and determination of intermediate versus definitive hosts.
• Standard Plate Count ($6-1$): Quantitative determination of viable bacterial cell concentrations using serial dilution techniques, spread and pour plating, countable plate criteria, and mathematical calculation of original cell density ($\text{OCD}$, titer).
• Spectrophotometer (Appendix E): Indirect quantification of microbial growth and cell density based on light scattering and absorbance (turbidimetry).
• Mannitol Salt Agar ($4-4$): Functional roles of selective ($7.5\%\,\text{NaCl}$) and differential (mannitol and phenol red) components in isolating halotolerant micrococci and distinguishing pathogenic Staphylococcus aureus from non-pathogenic Staphylococcus epidermidis.

Helminthology: Biology, Classification, and Medical Parasitology

• General Helminth Biology:

  • Helminths are multicellular, eukaryotic, invertebrate animals belonging to the animal kingdom; they can be either free-living or parasitic.
  • Monoecious (Hermaphroditic): An individual organism possess both functional male and female reproductive systems within a single body (e.g., Taenia solium).
  • Dioecious: Separate sexes exist as two distinct individual adult worms (male and female). In dioecious species, male worms are typically smaller than female worms (e.g., Schistosoma mansoni, Enterobius vermicularis, Ascaris lumbricoides, Necator americanus, Trichinella spiralis).
  • Host Classifications in Helminth Life Cycles:
    • Intermediate Host (IH): The host organism that harbors the larval, developmental, or asexual reproductive stages of the parasite.
    • Definitive Host (DH): The host organism that harbors the mature adult, sexually reproductive stage of the parasite.

• Taxonomic Organization and Pharmacological Treatment:

  • Phylum Platyhelminthes (Flatworms):
    • Class Cestoda (Cestodes / Tapeworms): Possess ribbon-like, segmented bodies lacking a digestive tract (e.g., Taenia solium).
    • Class Trematoda (Trematodes / Flukes): Possess flat, leaf-shaped, unsegmented bodies with incomplete digestive tracts (e.g., Schistosoma mansoni).
    • Antiparasitic Treatment: All Platyhelminthes in this study set are treated with Praziquantel.
  • Phylum Nematoda (Roundworms):
    • Cylindrical, unsegmented bodies with a complete, one-way digestive system (mouth, intestine, and anus).
    • Divided into two clinical categories based on the infectious form:
      • Infectious Egg Stage: Enterobius vermicularis, Ascaris lumbricoides.
      • Infectious Larval Stage: Necator americanus, Trichinella spiralis.
    • Antiparasitic Treatment: All Nematodes in this study set are treated with Mebendazole.

Clinical and Morphological Profiles of Selected Helminths

• Taenia solium (Pork Tapeworm):
  • Phylum & Class: Platyhelminthes; Cestoda.
  • Reproductive Strategy: Monoecious (hermaphroditic).
  • Diseases Caused:
    • Taeniasis: Intestinal tapeworm infection resulting from the ingestion of viable encysted larvae (cysticerci) in raw or undercooked pork.
    • Cysticercosis: Systemic tissue infection resulting from the ingestion of embryonated Taenia solium eggs via the fecal-oral route. Oncospheres hatch in the intestine, penetrate the gut wall, enter circulation, and encyst as cysticerci in subcutaneous tissue, skeletal muscle, eyes, and the central nervous system (neurocysticercosis).
  • Signs & Symptoms: Nausea, vomiting, abdominal discomfort; seizures and neurological deficits occur if cysticerci lodge in the brain.
  • Hosts:
    • Definitive Host ($\text{DH}$): Humans (harbor adult tapeworm in the small intestine).
    • Intermediate Host ($\text{IH}$): Swine/pigs (normally harbor cysticerci in muscle tissue); humans also act as intermediate hosts when eggs are ingested, resulting in cysticercosis.
  • Morphological Features:
    • Scolex (Head): Serves as an attachment organelle equipped with four prominent muscular suckers and a rostellum containing two concentric rings of chitinous hooks.
    • Neck: Germinative zone immediately posterior to the scolex that continuously generates immature proglottids.
    • Proglottids (Body Segments): The strobila consists of repeated segments containing both male (testes, sperm duct) and female (ovary, vitellaria, uterus, genital pore) reproductive structures. Mature/gravid proglottids become filled with eggs, detach, disintegrate, and pass out in feces.
    • Egg: Spherical shape surrounded by a thick, radially striated shell (embryophore) enclosing an oncosphere possessing six diagnostic hooks.
    • Cysticercus: A fluid-filled bladder cyst containing an invaginated scolex armed with hooks.
  • Treatment & Prevention: Treated with Praziquantel; prevented through thorough cooking of pork meat and strict fecal-oral sanitation.

• Schistosoma mansoni (Blood Fluke):
  • Phylum & Class: Platyhelminthes; Trematoda.
  • Reproductive Strategy: Dioecious (separate male and female adults).
  • Disease Caused: Schistosomiasis (specifically intestinal schistosomiasis; related species include Schistosoma japonicum, causing intestinal inflammation, and Schistosoma hematobium, causing inflammation of the urinary bladder wall).
  • Signs, Symptoms, & Complications: Blood in stool or urine, abdominal pain, enlarged liver (hepatomegaly), enlarged spleen (splenomegaly). Long-term complications include chronic liver damage, portal hypertension, and bladder cancer (associated with S. hematobium).
  • Pathogenesis: Adult worm pairs inhabit the mesenteric venules; females continuously deposit eggs that provoke an intense granulomatous inflammatory response as they migrate through vessel walls toward the intestinal lumen.
  • Hosts:
    • Definitive Host ($\text{DH}$): Humans.
    • Intermediate Host ($\text{IH}$): Freshwater aquatic snails (e.g., Biomphalaria).
  • Life Cycle & Transmission:
    1. Eggs are excreted into freshwater bodies via human feces or urine.
    2. Eggs hatch in water, releasing free-swimming ciliated larvae called miracidia ($0.2\,\text{mm}$).
    3. Miracidia locate and penetrate freshwater snail tissue.
    4. Inside the snail intermediate host, miracidia reproduce asexually, developing through sporocyst generations to yield thousands of free-swimming fork-tailed larvae called cercariae ($0.13-0.33\,\text{mm}$).
    5. Cercariae emerge from snails into the water column and directly penetrate intact human skin of waders or swimmers, shedding their tails to become schistosomulae.
    6. Schistosomulae enter venous circulation, transit through the heart and lungs, enter the portal circulation, and mature into adults within mesenteric blood vessels.
  • Morphological Features:
    • Adults: Demonstrate extreme sexual dimorphism. The adult male is shorter, broader, and features a longitudinal ventral groove called the gynecophoral canal ("split-body"), as well as suckers for host attachment. The female is long ($15-20\,\text{mm}$), slender, and resides continuously enclosed within the male's gynecophoral canal during copulation and egg deposition.
    • Egg: Features a prominent, sharply pointed lateral spine ($0.15\,\text{mm}$ length).
    • Cercaria: Possesses an elongated body and a fin-like bifurcated tail adapted for aquatic motility.
  • Treatment & Prevention: Treated with Praziquantel; prevented by eliminating freshwater snail populations, avoiding contact with untreated freshwater lakes/ponds, and improving community sanitation and human waste disposal.

• Enterobius vermicularis (Pinworm / Human Pinworm):
  • Phylum & Class: Nematoda; Secernentea.
  • Reproductive Strategy: Dioecious.
  • Disease Caused: Pinworm infection (enterobiasis).
  • Signs & Symptoms: Intense perianal itching (pruritus ani), especially nocturnal, leading to sleep disruption, restlessness, and secondary bacterial excoriation.
  • Hosts: Humans serve as both the intermediate host and the definitive host ($\text{DH/IH: Human}$).
  • Life Cycle & Transmission:
    1. Infectious embryonated eggs are ingested via contaminated fingers, food, toys, or fomites (bed sheets, clothing) following the scratch-to-mouth cycle.
    2. Larvae hatch within the small intestine.
    3. Larvae migrate to the cecum and appendix, where they mature into adult roundworms.
    4. At night, pregnant (gravid) females migrate out through the anus onto the perianal folds to deposit thousands of eggs, which become fully infectious within $4$ to $6\,\text{hours}$.
  • Morphological Features:
    • Adult Female: Small white worm characterized by a distinct, sharp, pin-like, pointed posterior tail.
    • Egg: Asymmetric, elongated, oval shell showing a characteristic flat side (flattened on one side, curved on the other; D-shaped appearance).
  • Treatment & Prevention: Treated with Mebendazole; prevented through strict hand hygiene, frequent handwashing, clipping fingernails, and laundering bed linens in hot water.

• Ascaris lumbricoides (Giant Intestinal Roundworm):
  • Phylum: Nematoda.
  • Reproductive Strategy: Dioecious.
  • Disease Caused: Ascariasis.
  • Signs & Symptoms: Often asymptomatic with low worm burden; high worm loads cause intestinal obstruction, malnutrition, abdominal distension, and pulmonary symptoms (coughing, wheezing) during larval transit.
  • Hosts: Humans serve as both intermediate and definitive hosts ($\text{DH/IH: Human}$).
  • Life Cycle & Transmission:
    1. Infection occurs via ingestion of soil-contaminated food or water carrying infectious embryonated eggs containing developed $L_3$ larvae (fecal-oral transmission).
    2. Larvae hatch within the small intestine, penetrate the intestinal mucosa, enter the bloodstream, and are transported through venous circulation to the lungs.
    3. Larvae break out of alveolar capillaries into lung alveoli, ascend the bronchial tree to the trachea and pharynx, are coughed up, and swallowed back into the esophagus.
    4. Larvae reach the small intestine a second time, where they mature into large adult roundworms that feed on luminal contents and shed eggs passed in feces.
  • Morphological Features:
    • Adults: Exceptionally large roundworms. Females are longer with straight posteriors; males are shorter and display a distinctly curved posterior tail equipped with copulatory spicules.
    • Eggs: Oval or round, characterized by a thick outer shell covered with bumpy, irregular proteinaceous ridges known as mammillations (mammillated or ruffled egg coat).
  • Treatment & Prevention: Treated with Mebendazole; prevented through sanitary disposal of human feces, avoiding night-soil fertilizer, and thorough washing of vegetables.

• Necator americanus (Hookworm / New World Hookworm):
  • Phylum: Nematoda.
  • Reproductive Strategy: Dioecious.
  • Disease Caused: Hookworm infection.
  • Signs & Symptoms: Often asymptomatic in mild cases; heavy chronic infections cause severe iron-deficiency anemia, fatigue, protein malnutrition, stunting in children, and local "ground itch" at the larval entry site. Heavy worm burden can also lead to intestinal blockage.
  • Pathogenesis: Adult worms latch onto the intestinal mucosa using sharp buccal cutting plates, lacerating host blood vessels and actively ingesting blood while secreting anticoagulants.
  • Hosts: Humans serve as both definitive and intermediate hosts ($\text{DH/IH: Human}$).
  • Life Cycle & Transmission:
    1. Infected individuals pass unembryonated eggs in their stool into warm, moist, shaded soil.
    2. Non-infectious rhabditiform larvae hatch in the soil within days.
    3. Rhabditiform larvae molt twice to develop into slender, motile, infectious filariform larvae.
    4. Filariform larvae directly penetrate unprotected bare human skin (typically barefoot contact with soil).
    5. Larvae enter circulation, migrate to the lungs, break into alveoli, are coughed up and swallowed, and mature into adults in the small intestine.
  • Morphological Features:
    • Mouth/Buccal Cavity: Armed with prominent ventral and dorsal chitinous cutting plates ($\text{CP}$) used to slice intestinal mucosa.
    • Adult Male Tail: Terminates in an umbrella-like, membranous copulatory bursa supported by fleshy rays used to grasp the female during mating.
    • Egg: Thin, smooth, completely clear shell containing an internal developing, segmented embryo (morula).
  • Treatment & Prevention: Treated with Mebendazole; prevented by wearing protective footwear ("beat your feet on the Mississippi mud, but please wear shoes") and establishing modern sanitary sewage systems.

• Trichinella spiralis (Trichina Worm):
  • Phylum: Nematoda.
  • Reproductive Strategy: Dioecious (longer female, shorter male).
  • Disease Caused: Trichinellosis (trichinosis).
  • Signs & Symptoms: Initial gastrointestinal phase involves abdominal pain, nausea, vomiting, and diarrhea; systemic migration and encystment cause high fever, periorbital edema (swelling around the eyes), subungual splinter hemorrhages, and intense skeletal muscle pain (myalgia).
  • Pathogenesis: Adult worms in the intestinal wall release newborn live larvae that enter lymphatic channels and blood vessels, distributing throughout the body to invade skeletal muscle fibers, modifying the host myocytes into specialized nurse cells surrounded by a fibrous collagenous capsule.
  • Hosts:
    • Definitive Host ($\text{DH}$): Humans (harbor adults in the intestine).
    • Intermediate Hosts ($\text{IH}$): Pigs, bears, cougars, walruses, wild boars, and rodents (harbor encysted larvae in skeletal muscle).
  • Transmission: Ingestion of infectious larvae encysted in raw or undercooked meat from infected swine or carnivores/game animals (e.g., bear meat, cougar, walrus).
  • Morphological Appearance: Diagnostic histology reveals tightly coiled, spiral-shaped larvae enclosed within oval, calcified or fibrous tissue capsules embedded between skeletal muscle fibers.
  • Treatment & Prevention: Treated with Mebendazole; prevented by thoroughly cooking pork and wild game to safe internal temperatures and preventing pigs from consuming uncooked animal carcasses or garbage.

Standard Plate Count and Quantitative Serial Dilution Methodology

• Fundamental Objective:

  • The primary purpose of the Standard Plate Count ($\text{Exercise 6-1}$) is to determine the viable Original Cell Density ($\text{OCD}$), also referred to as the concentration or titer, of a bacterial broth culture in units of colony forming units per milliliter ($\text{cfu/mL}$).

• Colony Forming Unit ($\text{CFU}$):

  • A single viable bacterial cell, pair, cluster, or chain that adheres to an agar surface, multiplies, and gives rise to an isolated, macroscopic bacterial mass called a colony.

• Statistical Counting Limits (Countable Plates):

  • A statistically valid, countable plate must contain between $30$ and $300\,\text{CFU}$.
  • Fewer than $30\,\text{CFU}$ ($<30\,\text{CFU}$): Considered Too Few To Count ($\text{TFTC}$); excluded from final calculations because sampling errors yield statistically unreliable, skewed estimations.
  • Greater than $300\,\text{CFU}$ ($>300\,\text{CFU}$): Considered Too Numerous To Count ($\text{TNTC}$); excluded from calculations because overcrowded colonies overlap, compete for nutrients, and suppress growth, preventing accurate manual counting.

Mathematical Formulas and Dilution Relationships

• Dilution Equation:$\text{Dilution} = \frac{\text{Sample volume in mL}}{\text{Total Volume in mL}}$

  • Dilution is a fraction representing concentration reduction and carries no units.
  • $\text{Total Volume in mL} = \text{Sample volume in mL} + \text{Diluent volume in mL}$.

• Dilution Factor ($\text{DF}$) Equation:$\text{Dilution Factor (DF)} = \text{Current dilution} \times \text{Previous DF}$$\text{DF} = \frac{\text{Sample volume in mL}}{\text{Total Volume in mL}} \times \text{Previous DF}$

  • $\text{DF}$ is dimensionless (no units).
  • The dilution factor of an undiluted original bacterial culture is always defined as $1$ ($\text{DF}_0 = 1$).

• Volume Plated ($\text{VP}$) Conversion:$\text{Volume Plated in mL} = \text{VP in }\mu\text{L} \times \frac{1\,\text{mL}}{1{,}000\,\mu\text{L}}$

• Final Dilution Factor ($\text{FDF}$):$\text{Final Dilution Factor (FDF)} = \text{DF} \times \text{VP in mL}$

  • In standard laboratory manuals and discussion problem sets, $\text{FDF}$ is also termed Sample Volume.
  • Because volume plated is expressed in milliliters, the unit of $\text{FDF}$ (Sample Volume) is $\text{mL}$.

• Original Cell Density ($\text{OCD}$) Formulation:$\text{OCD} = \frac{\text{CFU}}{\text{FDF}} = \frac{\text{CFU}}{\text{DF} \times \text{VP in mL}}$

  • $\text{OCD}$ is strictly expressed in $\text{cfu/mL}$.

Step-by-Step Serial Dilution Scheme and Plate Inoculation

• Sequential Transfer Calculations for a Standard 5-Tube Series:
  • Original Culture: $\text{DF}_0 = 1$.
  • Tube 1: Transfer $0.1\,\text{mL}$ of original culture into $9.9\,\text{mL}$ of sterile diluent:         $\text{DF}_1 = \frac{0.1\,\text{mL}}{0.1\,\text{mL} + 9.9\,\text{mL}} \times 1 = \frac{0.1}{10.0} = 10^{-2}$
  • Tube 2: Transfer $0.1\,\text{mL}$ from Tube 1 into $9.9\,\text{mL}$ of diluent:         $\text{DF}_2 = \frac{0.1\,\text{mL}}{0.1\,\text{mL} + 9.9\,\text{mL}} \times 10^{-2} = 10^{-2} \times 10^{-2} = 10^{-4}$
  • Tube 3: Transfer $1.0\,\text{mL}$ from Tube 2 into $9.0\,\text{mL}$ of diluent:         $\text{DF}_3 = \frac{1.0\,\text{mL}}{1.0\,\text{mL} + 9.0\,\text{mL}} \times 10^{-4} = 10^{-1} \times 10^{-4} = 10^{-5}$
  • Tube 4: Transfer $1.0\,\text{mL}$ from Tube 3 into $9.0\,\text{mL}$ of diluent:         $\text{DF}_4 = \frac{1.0\,\text{mL}}{1.0\,\text{mL} + 9.0\,\text{mL}} \times 10^{-5} = 10^{-1} \times 10^{-5} = 10^{-6}$
  • Tube 5: Transfer $1.0\,\text{mL}$ from Tube 4 into $9.0\,\text{mL}$ of diluent:         $\text{DF}_5 = \frac{1.0\,\text{mL}}{1.0\,\text{mL} + 9.0\,\text{mL}} \times 10^{-6} = 10^{-1} \times 10^{-6} = 10^{-7}$

• Plating and Colony Count Analysis ($100\,\mu\text{L} = 0.1\,\text{mL} = 10^{-1}\,\text{mL}$ plated per dish):
  • Plate A (from Tube 2, $\text{DF} = 10^{-4}$):$\text{FDF} = 10^{-4} \times 10^{-1}\,\text{mL} = 10^{-5}\,\text{mL}$Count: $>300\,\text{cfu}$ (e.g., $350\,\text{cfu}$, $\text{TNTC}$).
  • Plate B (from Tube 3, $\text{DF} = 10^{-5}$):$\text{FDF} = 10^{-5} \times 10^{-1}\,\text{mL} = 10^{-6}\,\text{mL}$Count: $38\,\text{cfu}$ (Countable, within the valid range of $30-300\,\text{cfu}$).
  • Plate C (from Tube 4, $\text{DF} = 10^{-6}$):$\text{FDF} = 10^{-6} \times 10^{-1}\,\text{mL} = 10^{-7}\,\text{mL}$Count: $15\,\text{cfu}$ ($\text{TFTC}$, below $30\,\text{cfu}$).
  • Plate D (from Tube 5, $\text{DF} = 10^{-7}$):$\text{FDF} = 10^{-7} \times 10^{-1}\,\text{mL} = 10^{-8}\,\text{mL}$Count: $3\,\text{cfu}$ ($\text{TFTC}$, below $30\,\text{cfu}$).
  • Calculation of Original Cell Density from Countable Plate B:$\text{OCD} = \frac{38\,\text{cfu}}{10^{-5} \times 10^{-1}\,\text{mL}} = \frac{38\,\text{cfu}}{10^{-6}\,\text{mL}} = 38 \times 10^6\,\text{cfu/mL} = 3.8 \times 10^7\,\text{cfu/mL}$

• Laboratory Plate Set 2 ($07\cdot 17\cdot 23$, Table #5):
  • Plate A: $>300\,\text{cfu}$ ($\text{TNTC}$, labeled $102$ dots in one quadrant, total $>300$).
  • Plate B: $>300\,\text{cfu}$ ($\text{TNTC}$).
  • Plate C: $94\,\text{cfu}$ (Countable Plate, falls between $30$ and $300\,\text{cfu}$).
  • Plate D: $8\,\text{cfu}$ ($\text{TFTC}$).
  • Calculation of $\text{OCD}$ using Plate C ($94\,\text{cfu}$, $\text{DF} = 10^{-6}$, $\text{VP} = 0.1\,\text{mL}$):$\text{OCD} = \frac{\text{CFU}}{\text{DF} \times \text{VP in mL}} = \frac{94\,\text{cfu}}{10^{-6} \times 0.1\,\text{mL}} = \frac{94\,\text{cfu}}{10^{-7}\,\text{mL}} = 94 \times 10^7\,\text{cfu/mL} = 9.4 \times 10^8\,\text{cfu/mL}$

Worked Practice Problems

• Practice Problem 1:

  • Problem Statement: Tube A contains $5\,\text{mL}$ of diluent. Exactly $1\,\text{mL}$ from a bacterial culture with $\text{DF} = 1$ is transferred into Tube A. What is the $\text{DF}$ of Tube A?
  • Step-by-Step Derivation:$\text{DF}_A = \frac{1\,\text{mL}}{1\,\text{mL} + 5\,\text{mL}} \times 1 = \frac{1}{6} \approx 0.17 = 1.7 \times 10^{-1}$
  • Answer: $0.17$ (or $1.7 \times 10^{-1}$, dimensionless).

• Practice Problem 2:

  • Problem Statement: Tube A and Tube B each contain $5\,\text{mL}$ of diluent. Transfer $1\,\text{mL}$ from an undiluted bacterial culture ($\text{DF}=1$) into Tube A. Then transfer $1\,\text{mL}$ from Tube A into Tube B. What is the $\text{DF}$ of Tube B?
  • Step-by-Step Derivation:$\text{DF}_A = \frac{1\,\text{mL}}{1\,\text{mL} + 5\,\text{mL}} \times 1 = \frac{1}{6}$$\text{DF}_B = \frac{1\,\text{mL}}{1\,\text{mL} + 5\,\text{mL}} \times \text{DF}_A = \frac{1}{6} \times \frac{1}{6} = \frac{1}{36} \approx 0.0277... \approx 0.03 = 3.0 \times 10^{-2}$
  • Answer: $0.03$ (or $3.0 \times 10^{-2}$, dimensionless).

• Practice Problem 3:

  • Problem Statement: Tube A has a dilution factor of $10^{-6}$. Add $1\,\text{mL}$ from Tube A into Tube B, which already contains $9\,\text{mL}$ of diluent. What is the $\text{DF}$ of Tube B?
  • Step-by-Step Derivation:$\text{DF}_B = \frac{1\,\text{mL}}{1\,\text{mL} + 9\,\text{mL}} \times 10^{-6} = \frac{1\,\text{mL}}{10\,\text{mL}} \times 10^{-6} = 10^{-1} \times 10^{-6} = 10^{-7}$
  • Answer: $10^{-7}$ (dimensionless).

• Practice Problem 4:

  • Problem Statement: Tube A and Tube B each contain $990\,\text{mL}$ of diluent. Transfer $10\,\text{mL}$ from an E. coli culture ($\text{DF}=1$) to Tube A. Then transfer $100\,\mu\text{L}$ from Tube A onto Plate A. What is the Final Dilution Factor ($\text{FDF}$)?
  • Step-by-Step Derivation:
    1. Compute $\text{DF}$ of Tube A:             $\text{DF}_A = \frac{10\,\text{mL}}{10\,\text{mL} + 990\,\text{mL}} \times 1 = \frac{10\,\text{mL}}{1{,}000\,\text{mL}} = 10^{-2}$
    2. Convert Volume Plated ($\text{VP}$) from $\mu\text{L}$ to $\text{mL}$:             $\text{VP} = 100\,\mu\text{L} \times \frac{1\,\text{mL}}{1{,}000\,\mu\text{L}} = 0.1\,\text{mL} = 10^{-1}\,\text{mL}$
    3. Compute $\text{FDF}$ (Sample Volume):             $\text{FDF} = \text{DF}_A \times \text{VP} = 10^{-2} \times 10^{-1}\,\text{mL} = 10^{-3}\,\text{mL}$
  • Answer: $10^{-3}\,\text{mL}$.

• Practice Problem 5:

  • Problem Statement: Tube B contains $99\,\text{mL}$ of diluent. Transfer $1\,\text{mL}$ from Tube A (which has a $\text{DF}$ of $10^{-5}$) into Tube B. Inoculate Plate B with $100\,\mu\text{L}$ from Tube B. Following incubation, exactly $133\,\text{colonies}$ are counted on Plate B. What is the Original Cell Density ($\text{OCD}$)?
  • Step-by-Step Derivation:
    1. Compute $\text{DF}$ of Tube B:             $\text{DF}_B = \frac{1\,\text{mL}}{1\,\text{mL} + 99\,\text{mL}} \times 10^{-5} = \frac{1\,\text{mL}}{100\,\text{mL}} \times 10^{-5} = 10^{-2} \times 10^{-5} = 10^{-7}$
    2. Convert volume plated:             $\text{VP} = 100\,\mu\text{L} = 0.1\,\text{mL} = 10^{-1}\,\text{mL}$
    3. Determine $\text{FDF}$:             $\text{FDF} = 10^{-7} \times 10^{-1}\,\text{mL} = 10^{-8}\,\text{mL}$
    4. Calculate $\text{OCD}$:             $\text{OCD} = \frac{133\,\text{cfu}}{10^{-8}\,\text{mL}} = 133 \times 10^8\,\text{cfu/mL} = 1.33 \times 10^{10}\,\text{cfu/mL}$
  • Answer: $1.33 \times 10^{10}\,\text{cfu/mL}$.

Standard Plate Count Discussion Questions

• Discussion Question 7:

  • Question: What is the dilution if $94\,\text{mL}$ of diluent is added to $4\,\text{mL}$ of a bacterial suspension?
  • Solution:$\text{Dilution} = \frac{\text{Sample Volume}}{\text{Total Volume}} = \frac{4\,\text{mL}}{4\,\text{mL} + 94\,\text{mL}} = \frac{4\,\text{mL}}{98\,\text{mL}} = \frac{2}{49} \approx 0.0408$

• Discussion Question 9:

  • Question: You were instructed to add $1.0\,\text{mL}$ out of $5.0\,\text{mL}$ of an undiluted sample to $99\,\text{mL}$ of sterile diluent. Instead, you add all $5.0\,\text{mL}$ to the $99\,\text{mL}$. What was the intended dilution and what was the actual dilution?
  • Solution:$\text{Intended Dilution} = \frac{1.0\,\text{mL}}{1.0\,\text{mL} + 99\,\text{mL}} = \frac{1.0\,\text{mL}}{100\,\text{mL}} = 10^{-2} = 0.01$$\text{Actual Dilution} = \frac{5.0\,\text{mL}}{5.0\,\text{mL} + 99\,\text{mL}} = \frac{5.0\,\text{mL}}{104\,\text{mL}} \approx 0.0481$

• Discussion Question 10:

  • Question: Suppose you were instructed to add $0.2\,\text{mL}$ of sample to $9.8\,\text{mL}$ of diluent, but instead added $2.0\,\text{mL}$ of sample. What was the intended dilution and what was the actual dilution?
  • Solution:$\text{Intended Dilution} = \frac{0.2\,\text{mL}}{0.2\,\text{mL} + 9.8\,\text{mL}} = \frac{0.2\,\text{mL}}{10.0\,\text{mL}} = 0.02 = 2.0 \times 10^{-2} = \frac{1}{50}$$\text{Actual Dilution} = \frac{2.0\,\text{mL}}{2.0\,\text{mL} + 9.8\,\text{mL}} = \frac{2.0\,\text{mL}}{11.8\,\text{mL}} \approx 0.1695$

• Discussion Question 11:

  • Question: Plating $1.0\,\text{mL}$ of a sample diluted by a factor of $10^{-3}$ produced $43\,\text{colonies}$. What was the original cell density in the sample?
  • Solution:$\text{OCD} = \frac{\text{CFU}}{\text{DF} \times \text{VP in mL}} = \frac{43\,\text{cfu}}{10^{-3} \times 1.0\,\text{mL}} = \frac{43\,\text{cfu}}{10^{-3}\,\text{mL}} = 43 \times 10^3\,\text{cfu/mL} = 4.3 \times 10^4\,\text{cfu/mL}$

• Discussion Question 12:

  • Question: Plating $0.1\,\text{mL}$ of a sample diluted by a factor of $10^{-3}$ produced $43\,\text{colonies}$. What was the original cell density in the sample?
  • Solution:$\text{OCD} = \frac{\text{CFU}}{\text{DF} \times \text{VP in mL}} = \frac{43\,\text{cfu}}{10^{-3} \times 0.1\,\text{mL}} = \frac{43\,\text{cfu}}{10^{-4}\,\text{mL}} = 43 \times 10^4\,\text{cfu/mL} = 4.3 \times 10^5\,\text{cfu/mL}$

• Discussion Question 13a:

  • Question: A plate with a sample volume (aka $\text{FDF}$) of $10^{-7}\,\text{mL}$ produced $72\,\text{colonies}$. What was the original cell density in the sample?
  • Solution:$\text{OCD} = \frac{\text{CFU}}{\text{Sample Volume (FDF)}} = \frac{72\,\text{cfu}}{10^{-7}\,\text{mL}} = 72 \times 10^7\,\text{cfu/mL} = 7.2 \times 10^8\,\text{cfu/mL}$

• Discussion Question 15:

  • Question: A nutrient agar plate that received $1{,}000\,\mu\text{L}$ of a bacterial sample diluted by a factor of $10^{-6}$ had $298\,\text{colonies}$ on it after incubation. What was the original cell density?
  • Solution:$\text{VP} = 1{,}000\,\mu\text{L} \times \frac{1\,\text{mL}}{1{,}000\,\mu\text{L}} = 1.0\,\text{mL}$$\text{OCD} = \frac{298\,\text{cfu}}{10^{-6} \times 1.0\,\text{mL}} = 298 \times 10^6\,\text{cfu/mL} = 2.98 \times 10^8\,\text{cfu/mL}$

• Discussion Question 16:

  • Question: You inoculated a nutrient agar plate with $100\,\mu\text{L}$ of a sample diluted by a factor of $10^{-3}$. After incubation, you count $58\,\text{colonies}$. What was the original cell density?
  • Solution:$\text{VP} = 100\,\mu\text{L} \times \frac{1\,\text{mL}}{1{,}000\,\mu\text{L}} = 0.1\,\text{mL} = 10^{-1}\,\text{mL}$$\text{OCD} = \frac{58\,\text{cfu}}{10^{-3} \times 10^{-1}\,\text{mL}} = \frac{58\,\text{cfu}}{10^{-4}\,\text{mL}} = 58 \times 10^4\,\text{cfu/mL} = 5.8 \times 10^5\,\text{cfu/mL}$

• Discussion Question 17a:

  • Question: A nutrient agar plate labeled $10^{-5}\,\text{mL}$ (the $\text{FDF}$, aka Sample Volume) produced $154\,\text{colonies}$ after incubation. What was the cell density in the original sample ($\text{OCD}$)?
  • Solution:$\text{OCD} = \frac{154\,\text{cfu}}{10^{-5}\,\text{mL}} = 154 \times 10^5\,\text{cfu/mL} = 1.54 \times 10^7\,\text{cfu/mL}$

Spectrophotometry and Indirect Microbial Enumeration

• Instrumentation Principles and Core Purpose:
  • The two primary purposes of the spectrophotometer (Appendix E) are to measure turbidity and to perform an indirect count of microbial cell numbers.
  • Direct vs. Indirect Counting:
    • A spectrophotometer cannot be used to directly measure or count the exact number of physical cells, nor can it provide a viable count alone, because it measures light extinction across both living and non-viable (dead) bacterial cells as well as cellular debris.
    • It is used to indirectly determine bacterial growth and estimate cell concentration based on culture turbidity.

• Physics of Optical Density and Turbidimetric Measurement:

  • Turbidity: A physical measure of light scattering/absorption caused by microbial particles suspended in a liquid medium.
  • Optical Mechanism:
    1. A light source emits parallel beams of radiant energy at a specified wavelength through a cuvette.
    2. A sterile uninoculated broth cuvette (blank) transmits all incident light directly to the light-sensitive detector, establishing the baseline calibration ($100\%$ transmittance, $0.0$ absorbance).
    3. When a bacterial suspension is placed in the light path, individual bacterial cells scatter light rays away from the optical axis so that they fail to strike the light-sensitive photocell detector.
    4. The instrument calculates light absorption/extinction expressed as Optical Density ($\text{OD}$) or Absorbance ($\text{A}$) units.

• Quantitative Relationship Between Light Absorption, Turbidity, and Cell Mass:

  • $\uparrow\text{Absorbance (OD)} \iff \uparrow\text{Turbidity} \iff \uparrow\text{Bacterial Cell Density}$
  • Example: A culture with an absorbance reading of $A = 0.675$ exhibits greater turbidity and contains a higher concentration of bacterial cells than a culture reading $A = 0.345$.
  • Rule: The greater the absorbance, the greater the turbidity, and the greater the number of bacteria.

Mannitol Salt Agar: Selective and Differential Media

• Laboratory Objective ($\text{Exercise 4-4}$):

  • To selectively isolate halotolerant micrococci (specifically Staphylococcus species) and presumptively identify pathogenic Staphylococcus aureus based on mannitol carbohydrate fermentation.

• Morphological and Ecological Distinctions: Staphylococcus vs. Streptococcus:

  • Microscopic Arrangement:
    • Staphylococcus: Spherical cocci dividing along multiple random planes to form irregular, grape-like clusters.
    • Streptococcus: Spherical cocci dividing along a single linear axis to form chain-like arrangements.
  • Ecological Niche:
    • Staphylococcus: Adapted to dry, high-osmotic, salty surfaces such as human skin, epidermal pores, and anterior nares.
    • Streptococcus: Adapted to moist, protected mucosal membrane environments (e.g., pharynx, throat, oral cavity).
  • Osmotic Tolerance:
    • Staphylococcus: Halotolerant (can withstand elevated osmotic pressure and high salt concentrations; grows vigorously on $7.5\%\,\text{NaCl}$).
    • Streptococcus: Non-halotolerant (cannot withstand elevated osmotic pressure; plasmolysis occurs and growth is completely inhibited on $7.5\%\,\text{NaCl}$).
  • Shared Characteristics: Both genera are Gram-positive cocci (staining purple upon Gram staining).

Biochemical Composition of Mannitol Salt Agar Media

• $7.5\%\,\text{Sodium Chloride (NaCl)}$ (Selective Agent):
  • Creates an exceptionally high osmotic pressure environment.
  • Selects for halotolerant bacteria (such as Staphylococcus spp.) while selectively dehydrating and inhibiting non-halotolerant organisms (including Streptococcus, Gram-negative bacilli, and most other commensal bacteria) via hypertonic plasmolysis.
• Mannitol ($1\%$) (Differential Substrate):
  • A six-carbon sugar alcohol added as a specific fermentable carbohydrate energy source.
  • Fermentation of mannitol yields acidic organic end products that lower the pH of the agar medium.
• Phenol Red (pH Indicator):
  • Incorporated to visually register shifts in hydrogen ion concentration ($\text{pH}$):
    • Yellow: Indicates an acidic pH ($\text{pH} \le 6.8$), resulting from mannitol fermentation.
    • Red / Red-Orange: Indicates a neutral to alkaline pH ($\text{pH} \approx 7.4 - 8.4$), reflecting lack of mannitol fermentation.
    • Deep Pink / Bright Red: Indicates an alkaline pH ($\text{pH} \ge 8.4$), resulting from peptone catabolism and ammonia release.
• Peptone (General Nutritional Base):
  • Provides essential nitrogen, amino acids, and minerals required for general bacterial metabolism.
  • Organisms incapable of fermenting mannitol utilize peptone as their primary respiratory substrate; enzymatic deamination of peptone amino acids releases alkaline end products (such as ammonia, $\text{NH}_3$), maintaining or driving the medium to a deep red color.

Comparative Diagnostics: Staphylococcus aureus versus Staphylococcus epidermidis

• Staphylococcus aureus:

  • Epidemiology: Colonizes approximately $30\%$ of healthy human populations, primarily in the anterior nares and skin.
  • Pathogenicity & Virulence: An opportunistic and primary pathogen; produces the enzyme coagulase, which clots blood plasma by converting fibrinogen to fibrin, forming protective mechanical barricades that shield the bacteria from phagocytosis.
  • Mannitol Fermentation: Positive (+). Readily ferments mannitol into acidic products, causing the phenol red pH indicator within the agar surrounding the colonies to change from red to bright YELLOW.
  • Coagulase Test: Positive (+).

• Staphylococcus epidermidis:

  • Epidemiology: Colonizes $100\%$ of human beings, constituting roughly $90\%$ of normal cutaneous microbiota.
  • Pathogenicity: Normal skin commensal; lacks coagulase (coagulase-negative staphylococcus), rarely causing primary disease except in immunocompromised patients or via indwelling medical devices.
  • Mannitol Fermentation: Negative (-). Cannot ferment mannitol; catabolizes peptone instead, producing alkaline metabolic byproducts that cause the phenol red indicator to remain RED (or develop a deeper red/pink tint).
  • Coagulase Test: Negative (-).

Questions & Review Discussion

• Helminth Identification Checks:

  • Question: Is Taenia solium shown on the slide containing a paired male and female fluke?
    • Response: No. The organism shown is Schistosoma mansoni (characterized by a wider male with gynecophoral groove clasping a slender female).
  • Question: What worm is shown by an egg displaying a distinct flattened side?
    • Response: Enterobius vermicularis (pinworm egg).
  • Question: What worm egg is shown by an oval displaying a clear outer shell surrounding an internal embryo?
    • Response: Necator americanus (hookworm egg).
  • Question: What worm egg is shown displaying a thick, heavily mammillated (ruffled) outer coat?
    • Response: Ascaris lumbricoides egg.
  • Question: Is the worm Ascaris lumbricoides monoecious or dioecious?
    • Response: Dioecious (consists of two separate adult worms: a longer female and a shorter male with a curved posterior tail).
  • Question: Is the encysted larval state of Taenia solium called cysticerci?
    • Response: True.
  • Question: What organism produces an egg with a thick, radially striated shell and 6 internal hooks?
    • Response: Taenia solium.
  • Question: What is the intermediate host of Schistosoma mansoni?
    • Response: Freshwater aquatic snail.
  • Question: What morphological structure represents a detached, hermaphroditic reproductive body segment of a tapeworm?
    • Response: Proglottid.

• Standard Plate Count Checks:

  • Question: What is the purpose of the Standard Plate Count?
    • Response: To determine the Original Cell Density ($\text{OCD}$), or titer/concentration, of viable bacteria in a culture in units of $\text{cfu/mL}$.
  • Question: How many CFUs are considered a statistically valid, countable plate?
    • Response: $30 - 300\,\text{CFU}$.

• Spectrophotometer Checks:

  • Question: What are two primary purposes of using a spectrophotometer in microbiology?
    • Response: 1. Measure turbidity and 4. Indirect count.
  • Question: True or False: The spectrophotometer directly measures the exact number of viable cells in a bacterial suspension.
    • Response: False. It measures turbidity (total light scattering from both living and dead cells) to estimate bacterial density indirectly.
  • Question: Complete the relationship: The greater the absorbance, the (lesser/greater) the turbidity, and the (lesser/greater) the bacterial count.
    • Response: The greater the absorbance, the greater the turbidity, and the greater the bacterial count.

• Mannitol Salt Agar Checks:

  • Question: What is the clinical purpose of the MSA plate?
    • Response: To select for halotolerant Staphylococcus species and presumptively identify pathogenic, mannitol-fermenting Staphylococcus aureus.
  • Question: Which specific chemical ingredient makes Mannitol Salt Agar selective?
    • Response: Sodium chloride ($7.5\%\,\text{NaCl}$).
  • Question: Which specific ingredients make the MSA plate differential?
    • Response: Mannitol (fermentable sugar alcohol) and Phenol red (pH indicator).
  • Question: An unknown Gram-positive coccus grows abundantly on MSA and turns the surrounding medium bright yellow. What is the metabolic result and presumptive identification?
    • Response: The organism ferments mannitol to produce acidic end products, presumptively identifying it as Staphylococcus aureus (coagulase-positive).